Recent studies have highlighted the role of aldehyde dehydrogenase (ALDH) activity in mediating resistance to therapy in multiple cancers, including breast, pancreatic, lung, Ewing’s sarcoma, stomach, glioblastoma, head and neck, ovarian, and colorectal cancers. Here, LDHA is linked to cancer.